Investorideas.com breaking new for AI and tech stocks

Thursday, August 8, 2019

The #AIEye: Nuance (NasdaqGS: $NUAN) Names Board of Directors for Automotive Spin-Off Company and Veritone (NasdaqGM: $VERI) One Announces Influencer Bridge for Content Creators


The #AIEye: Nuance (NasdaqGS: $NUAN) Names Board of Directors for Automotive Spin-Off Company and Veritone (NasdaqGM: $VERI) One Announces Influencer Bridge for Content Creators

Global Healthcare #AI Market to See 51.9% CAGR from 2018-2023




Point Roberts WA, Vancouver BC – August 8, 2019  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:



Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NasdaqGS:NUAN) (NasdaqGM:VERI)

Nuance Communications, Inc. (NasdaqGS:NUAN) has named the board of directors for its automotive spin-off company, Cerence Inc. Arun Sarin, former CEO of Vodafone, will be appointed Cerence Chairman of the Board when the spin-off is completed on October 1, 2019. Also named to the board is Sanjay Dhawan, who  previously served as president of the Connected Services Division and chief technology officer of Harman Industries International since 2015. According to the press release, “Dhawan brings a deep understanding of AI and machine learning applications, with a focus on developing solutions at the intersection of devices, sensors, cloud solutions and data integration”. Mark Benjamin, CEO of Nuance, commented:

“For Cerence’s future Board of Directors, we have assembled a group of highly talented leaders who bring a variety of meaningful, deep talent and expertise. As Nuance prepares to spin the automotive business into Cerence, the extensive knowledge, unique insights, and proven success of this board will serve Cerence and its shareholders well and will be integral to the company’s bright future.”

Veritone One, a wholly-owned subsidiary of Veritone, Inc. (NasdaqGM:VERI), is launching a pay-per-performance advertising platform for audio and video content creators called Influencer Bridge. The platform will leverage Veritone’s AI-powered aiWARE to “listen, watch and understand the content of each podcast episode and YouTube video included in the Influencer Bridge program”. Ryan Steelberg, President of Veritone One, explained:

“Influencer Bridge gives all influencers – whether established or up and coming – a seat at the table by enabling them to monetize their content without much time investment and at no cost. In turn, advertisers can expand their reach and also have the opportunity to advertise to a hyper-targeted audience in engaging and authentic ways. We are excited to kick-off the launch of a series of new advertising services with this unique offering that benefits both content creators and advertisers.”


Global Healthcare AI Market to See 51.9% CAGR from 2018-2023

A report from Market Research Future finds that the global Healthcare Artificial Intelligence market will see a compound annual growth rate (CAGR) of 51.9 percent in the forecast period 2018 to 2023. An excerpt outlines the market dynamics:

Artificial intelligence (AI) is being used for a range of healthcare and research purposes, such as detection of diseases, management of chronic conditions, delivery of health services, and drug discovery. AI applications and systems deliver new efficiencies and possibilities which empower healthcare professionals and researchers to improve their quality of work and enhance the lives of patients. Artificial intelligence is algorithms which are capable of analyzing complex research data. Their potential to exploit meaningful relationship within a data set can be used in precision medicine, drug discovery, and predicting outcome in a wide range of clinical scenarios. AI is advancing in clinical research as it has the potential to overcome many clinical trial challenges such as matching eligible patients for research and monitoring adherence and data collection. For instance, Deep 6 AI founded in 2015 and headquartered in California, has developed a Deep 6 AI, an artificial intelligence-enabled technology platform, that finds eligible patients for clinical trials faster and analyses complex clinical data. Thus, the application of AI in research helps scientists to speed up their research and get life-saving cures more quickly.

Sam Mowers, Investorideas.com

For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Contact Investorideas.com
800 665 0411


  



Get more tech stocks investor ideas- news, articles, podcasts  and stock directories





No comments:

Post a Comment